We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

002304:SZSEJiangsu Yanghe Distillery Co., Ltd. Analysis

Data as of 2026-03-16 - not real-time

CN¥51.76

Latest Price

5/10Risk

Risk Level: Medium

Executive Summary

The stock is trading at CNY 51.76, well below its 20‑day (52.6), 50‑day (57.2) and 200‑day (65.3) moving averages, signalling a bearish technical backdrop. RSI sits at 38, hinting at modest oversold pressure, while the MACD shows a small bullish histogram (+0.235) against a still‑negative line, suggesting limited short‑term upside. Volatility is high at 50% over the past 30 days, yet beta is exceptionally low, indicating the price swings are largely idiosyncratic.
Fundamentally, the DCF‑derived fair value of roughly CNY 23.4 is far beneath the current price, marking the stock as overvalued. The dividend yield looks attractive at 9%, but a payout ratio of 338% raises serious sustainability concerns. Operating margins are negative (-16%) despite a solid cash pile (CNY 21.8 bn) and modest debt, and the forward PE of 15 suggests modest earnings improvement ahead. Overall, the combination of technical weakness, valuation gap, and dividend risk tempers enthusiasm despite the defensive beverage sector positioning.

Market Outlook

Short Term

< 1 year
Cautious
Model confidence: 6/10

Key Factors

  • Price below all major moving averages indicating bearish momentum
  • Overvaluation relative to DCF fair value
  • Unsustainable dividend payout ratio

Medium Term

1–3 years
Neutral
Model confidence: 5/10

Key Factors

  • Potential earnings recovery reflected in forward PE of 15
  • Strong cash position offsets operating losses
  • Defensive consumer sector provides stability

Long Term

> 3 years
Neutral
Model confidence: 4/10

Key Factors

  • Brand legacy and market presence in Chinese baijiu market
  • Continued cash generation capacity
  • Persistent valuation premium and regulatory headwinds

Key Metrics & Analysis

Financial Health

Revenue Growth-29.00%
Profit Margin10.64%
P/E Ratio37.8
ROE4.02%
ROA3.09%
Debt/Equity0.33
P/B Ratio1.6
Op. Cash FlowCN¥2.1B
Free Cash FlowCN¥1.0B

Technical Analysis

TrendBearish
RSI38.2
SupportCN¥50.14
ResistanceCN¥56.10
MA 20CN¥52.62
MA 50CN¥57.22
MA 200CN¥65.33
MACDBullish
VolumeStable
Fear & Greed Index78.29

Valuation

Fair ValueCN¥23.41
Target PriceCN¥68.84
Upside/Downside33.01%
GradeOvervalued
TypeValue
Dividend Yield9.07%

Risk Assessment

Beta0.06
Volatility50.10%
Sector RiskLow
Reg. RiskMedium
Geo RiskMedium
Currency RiskLow
Liquidity RiskLow

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.